Results 151 to 160 of about 119,004 (251)

Blepharospasm in GNAO1 Syndrome May Benefit From Botulinum Toxins. [PDF]

Mov Disord Clin Pract
Minacapilli E, Devigili G, Zorzi G, Giordano F, Graziola F.   +4 more
europepmc   +1 more source

Gastrocnemius muscle properties in children with cerebral palsy: An exploratory cross‐sectional study of variability in gastrocnemius properties

Experimental Physiology, EarlyView.
Abstract Muscle strength is a key predictor of physical functioning, yet the influence of patient and treatment factors on muscle properties in young people with cerebral palsy is not fully known. We explored whether medial gastrocnemius properties vary by age, ambulatory status and spasticity treatment (botulinum toxin or selective dorsal rhizotomy ...
Elizabeth R. Boyer, Christiana J. Raymond‐Pope, Daniel B. Hoffman, Marshall H. Taniguchi, Tom F. Novacheck, Braydon A. Crum, Peter D. Kim, Sarah M. Greising   +7 more
wiley   +1 more source

Introduction to <i>Toxins</i> Special Issue on Botulinum Toxins: New Uses in the Treatment of Diseases (2nd Edition). [PDF]

Toxins (Basel)
Luvisetto S.
europepmc   +1 more source

New Engineered-Botulinum Toxins Inhibit the Release of Pain-Related Mediators. [PDF]

Int J Mol Sci, 2019
Tang M, Meng J, Wang J.
europepmc   +1 more source

Bacterial Protein Toxins as Anticancer Agents: Clinical Potential of Pseudomonas and Anthrax Toxins

Protein toxins are biologically active polypeptides produced by a variety of organisms, including bacteria, plants, fungi, and animals. These molecules exert potent and specific toxic effects on target cells and are primarily associated with ...
Radhika Gupta, Vishal Sharma, Namita Nayyar, Yogendra Singh, Renu Baweja, Richa Misra, Ritvik Baweja   +6 more
core   +1 more source

Third Space Endoscopic Therapies for Benign Motility Disorders: A Narrative Review

DEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT Objectives To review the evidence base, evolution, outcomes, adverse events (AEs), and management for third‐space endoscopy (TSE) procedures for management of benign motility disorders. Methods This review examines TSE procedures for motility disorders, reviewing the current available techniques, success, outcomes, and long‐term outcomes from ...
Sanjana Bhagwat, Amol Bapaye
wiley   +1 more source

Botulinum toxins for the prevention of migraine in adults. [PDF]

Cochrane Database Syst Rev, 2018
Herd CP, Tomlinson CL, Rick C, Scotton WJ, Edwards J, Ives N, Clarke CE, Sinclair A.   +7 more
europepmc   +1 more source

Successful treatment of Hailey–Hailey disease (HHD) with the IL‐13 inhibitor lebrikizumab

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Elena Schneider, Maike M. Holtsche, Ulrike Raap, Nikolaos Patsinakidis   +3 more
wiley   +1 more source

Predictive Contribution of Clinical Measures of Ankle Neuromuscular Impairments to Ankle Kinematic Deviations During Gait in Children With Cerebral Palsy

Journal of Foot and Ankle Research, Volume 19, Issue 4, December 2026.
ABSTRACT Introductions Children with cerebral palsy (CP) commonly exhibit neuromuscular impairments that affect ankle motion during gait. These include hypertonia, muscle weakness, poor selective motor control, and restricted range‐of‐motion. However, their individual and combined impacts on sagittal ankle kinematics remain unclear. This study aimed to
Faustyna Manikowska, Sabina Brazevic, Brian Po‐Jung Chen, Marek Jóźwiak, Maria K. Lebiedowska   +4 more
wiley   +1 more source

The Esthetic Use of Botulinum Toxins in Cancer Patients: Providing a Foundation for Future Indications. [PDF]

Toxins (Basel)
Papagni M, Renga M, Mogavero S, Veronesi P, Cavallini M.   +4 more
europepmc   +1 more source